Market News AIOpen the app

AVIR stock news · Atea Pharmaceuticals, Inc.

Stories about Atea Pharmaceuticals, Inc. (AVIR) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AVIR

Follow Atea Pharmaceuticals, Inc. (AVIR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AVIR
Free on the App Store and Google Play, or on the web.
  1. Nov 9, 2026, 7:56 AM ET · Market

    Atea Pharmaceuticals has signed a loan deal with Hercules Capital, Inc.

    Neutral

    Atea filed a loan agreement with Hercules Capital as agent for lenders and reported debt. The filing gives no amount or repayment details, so it does not change Atea's outlook.